Potassium Inwardly-Rectifying Channel, Subfamily J, Member 5 (KCNJ5) Peptide
-
- Target See all KCNJ5 products
- KCNJ5 (Potassium Inwardly-Rectifying Channel, Subfamily J, Member 5 (KCNJ5))
- Origin
- Human, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-Kir3.4 Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- KCNJ5 (Potassium Inwardly-Rectifying Channel, Subfamily J, Member 5 (KCNJ5))
- Synonyms
- CIR Peptide, GIRK4 Peptide, KATP1 Peptide, KIR3.4 Peptide, LQT13 Peptide, Kir3.4 Peptide, GIRK-4 Peptide, KATP-1 Peptide, potassium voltage-gated channel subfamily J member 5 Peptide, potassium inwardly-rectifying channel, subfamily J, member 5 Peptide, KCNJ5 Peptide, Kcnj5 Peptide
- Background
- GIRK4, G protein-activated inward rectifier potassium channel 4, GIRK-4, Cardiac inward rectifier, CIR, Heart KATP channel, Inward rectifier K(+) channel Kir3.4, IRK-4, KATP-1, Potassium channel, inwardly rectifying subfamily J member 5
- Gene ID
- 3762, 16521, 29713
- UniProt
- P48544, P48545, P48548
-